Quarterly report pursuant to Section 13 or 15(d)

Grant Revenue (Details)

v3.19.3
Grant Revenue (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 31, 2017
May 31, 2017
Jun. 30, 2016
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Deferred Revenue Arrangement [Line Items]              
Revenue       $ 6,439 $ 1,840,009 $ 1,049,988 $ 3,735,713
Grant Revenue [Member]              
Deferred Revenue Arrangement [Line Items]              
Amount awarded from CPRIT grant           8,300,000  
Pelican Therapeutics, Inc. [Member]              
Deferred Revenue Arrangement [Line Items]              
Amount awarded from CPRIT grant     $ 15,200,000        
Contract value           $ 7,600,000  
Pelican Therapeutics, Inc. [Member] | Tranche I [Member]              
Deferred Revenue Arrangement [Line Items]              
Revenue   $ 1,800,000          
Pelican Therapeutics, Inc. [Member] | Tranche II [Member]              
Deferred Revenue Arrangement [Line Items]              
Revenue $ 6,500,000